As a noninvasive marker, VEGF-C has the potential to clinically expedite the diagnosis of ovarian cancer and to aid in the detection of lymph node metastasis in women for whom CA125 is not useful. Here, VEGFC is linked to metastatic malignant neoplasm in the lymph nodes.